CN114478525B - Tetrahydro-beta-carboline pyrazole amide derivative and preparation method and application thereof - Google Patents

Tetrahydro-beta-carboline pyrazole amide derivative and preparation method and application thereof Download PDF

Info

Publication number
CN114478525B
CN114478525B CN202210310789.5A CN202210310789A CN114478525B CN 114478525 B CN114478525 B CN 114478525B CN 202210310789 A CN202210310789 A CN 202210310789A CN 114478525 B CN114478525 B CN 114478525B
Authority
CN
China
Prior art keywords
tetrahydro
carboline
amide derivative
pyrazole
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210310789.5A
Other languages
Chinese (zh)
Other versions
CN114478525A (en
Inventor
成道泉
李永红
刘建成
王祥传
于晓静
吴磊
张耀中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong Jingbo Agrochemical Technology Co ltd
Original Assignee
Shandong Jingbo Agrochemical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Jingbo Agrochemical Technology Co ltd filed Critical Shandong Jingbo Agrochemical Technology Co ltd
Priority to CN202210310789.5A priority Critical patent/CN114478525B/en
Publication of CN114478525A publication Critical patent/CN114478525A/en
Application granted granted Critical
Publication of CN114478525B publication Critical patent/CN114478525B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention provides a tetrahydro-beta carboline pyrazole amide derivative, which has a structure shown in a formula I. The invention provides a series of amide compounds with novel structures, which have higher antibacterial activity, in particular to the bactericidal activity of rhizoctonia solani, rhizoctonia cerealis, sclerotinia sclerotiorum, botrytis cinerea, downy mildew of tomato and the like, and have market application prospect as plant antibacterial agents.

Description

Tetrahydro-beta-carboline pyrazole amide derivative and preparation method and application thereof
Technical Field
The invention relates to the technical field of pesticides, in particular to a tetrahydro-beta-carboline pyrazole amide derivative, and a preparation method and application thereof.
Background
Plant diseases have an adverse effect on plant growth, and it is important to control plant diseases caused by plant pathogenic fungi. Bactericides can solve plant diseases to some extent, however, the types of bactericides are newer slowly, and some bactericides develop resistance quickly.
The Chinese patent with the application publication number of CN101020688 discloses a derivative containing a tetrahydro-beta carboline skeleton, which has antibacterial activity, but has harsh reaction conditions and is not easy to produce and convert.
It is therefore of great importance to develop new compounds which are more potent, more economical, less toxic or have different sites of action.
Disclosure of Invention
In order to solve the problems, the invention provides a tetrahydro-beta carboline pyrazole amide derivative, a preparation method and application thereof, and the prepared tetrahydro-beta carboline pyrazole amide derivative has higher antibacterial activity.
The invention provides a tetrahydro-beta carboline pyrazole amide derivative, which has a structure shown in a formula I:
Figure BDA0003568142520000011
wherein R is 1 、R 3 Independently selected from one or more of H, halogen, C1-C6 alkyl, nitro, cyano, C1-C6 alkoxy, C1-C6 alkoxycarbonyl, hydroxyl, ester, difluoromethyl, trifluoromethyl, difluoromethoxy, trifluoromethoxy, phenyl, halogen-containing substituted phenyl and pyridyl;
R 2 is benzyloxy, methoxy;
R 4 selected from H, halogen, C1-C6 alkyl or C1-C6 alkoxy;
R 5 selected from H, C-C6 alkyl, C1-C6 formate, C1-C6 acetate, C1-C6 acyl;
x is O or S;
n is an integer of 1 to 3;
m is an integer of 1 to 4;
q is 1 or 2.
Wherein the R is 1 Preferably H, halogen, C1-C6 alkyl, nitro, cyano, C1-C6 alkoxy, C1-C6 alkoxycarbonyl, hydroxy, ester, difluoromethyl, trifluoromethyl, difluoromethoxy, trifluoromethoxy, phenyl, halogen-containing substituted phenyl or pyridyl; more preferably H, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkoxycarbonyl, ester group, difluoromethyl, trifluoromethyl, difluoromethoxy, trifluoromethoxy, phenyl or halogen-containing substituted phenyl; further preferred is H, F, cl, br, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, difluoromethyl, trifluoromethyl, difluoromethoxy, trifluoromethoxy, phenyl or ethoxycarbonyl.
As a preferred embodiment, the tetrahydro- β carboline pyrazole amide derivative of the present invention has any one of the compounds shown in table 1 of the general formula i.
TABLE 1
Figure BDA0003568142520000021
Figure BDA0003568142520000031
Preferably, the R 1 Is substituted in the 3-or 4-position.
The R is 2 Preferably benzyloxy and methoxy.
Preferably, said R 3 、R 4 、R 5 All are H.
Preferably, X is O.
Preferably, n, m and q are all 1.
Preferably, the tetrahydro-beta carboline pyrazole amide derivative has any one of the following structures:
Figure BDA0003568142520000041
the invention also provides a preparation method of the tetrahydro-beta carboline pyrazole amide derivative, which comprises the following steps:
and mixing the tetrahydro-beta carboline amide and the pyrazole derivatives in a solvent, and reacting under the action of an acid binding agent and thionyl chloride to obtain the tetrahydro-beta carboline pyrazole amide derivatives.
The solvent is preferably one or more of toluene, xylene, dichloromethane, dichloroethane, methyl tert-butyl ether, tetrahydrofuran, dioxane, ethylene glycol dimethyl ether, acetone, ethyl acetate and acetonitrile; toluene is more preferred.
The acid binding agent is preferably a basic compound.
The alkaline compound is preferably one or more of potassium carbonate, sodium carbonate, potassium bicarbonate, sodium bicarbonate, triethylamine and pyridine; more preferably triethylamine.
The temperature of the reaction is preferably 5-70 ℃; more preferably 5 to 10 ℃.
Preferably, the preparation method specifically comprises the following steps:
s1) mixing tetrahydro-beta carboline amide and pyrazole derivatives in a solvent, and reacting under the action of an acid binding agent and thionyl chloride;
s2) after the reaction is finished, regulating the pH value of the system to 1-2, and separating to obtain an organic phase;
and S3) drying and purifying the organic phase to obtain the tetrahydro-beta carboline pyrazole amide derivative.
Preferably, the thionyl chloride is added in a dropwise manner.
The temperature of dropwise adding thionyl chloride is preferably-10-20 ℃; more preferably 5 to 10 ℃.
The purification mode of the present invention is not particularly limited, and may be a purification mode known to those skilled in the art, such as recrystallization, column chromatography, etc., and the present invention preferably employs a column chromatography, and the eluent for the column chromatography is preferably an ethyl acetate-petroleum ether system.
The invention also provides application of the tetrahydro-beta carboline pyrazole amide derivative or the tetrahydro-beta carboline pyrazole amide derivative prepared by the preparation method as an active ingredient of an antibacterial agent.
The invention also provides an antibacterial agent, which comprises the tetrahydro-beta carboline pyrazole amide derivative or the tetrahydro-beta carboline pyrazole amide derivative prepared by the preparation method.
In the invention, the tetrahydro-beta carboline pyrazole amide derivative can be used as the only active ingredient or used in combination with other antibacterial agents or antiviral agents.
Compared with the prior art, the invention provides a tetrahydro-beta carboline pyrazole amide derivative which has a structure shown in a formula I. The invention provides a series of amide compounds with novel structures, which have higher antibacterial activity, in particular to rhizoctonia solani, rhizoctonia cerealis, sclerotinia sclerotiorum, botrytis cinerea and downy mildew of tomato, and have remarkable bactericidal activity and good market application prospect as plant antibacterial agents.
Drawings
FIG. 1 is a nuclear magnetic resonance hydrogen spectrum of compound 1;
FIG. 2 is a nuclear magnetic resonance hydrogen spectrum of compound 3;
FIG. 3 is a nuclear magnetic resonance hydrogen spectrum of compound 7.
Detailed Description
In order to further illustrate the invention, the following describes the tetrahydro-beta carboline pyrazole amide derivative, the preparation method and the application thereof in detail by combining the examples.
Example 1 preparation of Compound 1
Figure BDA0003568142520000061
Tetrahydro-beta carboline monoamide (19 g) was added to a 500ml three-necked flask, then anhydrous toluene (190 ml) was added, pyrazole (3.55 g) was added under stirring, and stirring was maintained at a temperature of 5-10℃for 10min. Then adding triethylamine (17.57 g), stirring for 5min at the temperature, slowly dropwise adding thionyl chloride (6.2 g) into the system, after the completion of the dropwise adding, keeping the temperature at 5-10 ℃ for reaction for 12h, adding water into the system after the completion of the central control of the reaction, acidifying to pH=1-2, separating out an organic layer, washing the organic layer for three times, drying by anhydrous sodium sulfate, and separating by column chromatography (ethyl acetate: petroleum ether=1:3) to obtain the compound 1.
1 H NMR(400MHz,DMSO-d 6 ):δ11.00-11.05(d,1H),8.35(s,1H),7.99-8.01(d,1H),7.29-7.45(m,7H),7.05-7.08(t,1H),6.94-6.97(t,1H),6.65(s,lH),6.43-6.45(dd,1H),5.15-5.29(m,3H),3.26-3.38(m,2H),1.64-1.72(dd,3H)。
The nuclear magnetic hydrogen spectrum of the compound 1 is shown in figure 1.
Example 2 preparation of Compound 2
Figure BDA0003568142520000071
The preparation method of the compound 2 is the same as that of the compound 1, and pyrazole is replaced by 4-chloropyrazole.
1 H NMR(400MHz,DMSO-d 6 ):δ10.94-11.02(d,1H),8.40(s,1H),7.97-8.05(m,2H),7.14-7.54(m,6H),7.04-7.07(t,1H),6.93-6.96(t,1H),6.48-6.58(d,1H),5.17-5.28(m,3H),3.31-3.04(m,2H),1.57-1.59(dd,3H)。
EXAMPLE 3 preparation of Compound 3
Figure BDA0003568142520000072
The preparation method of the compound 3 is the same as that of the compound 1, and pyrazole is replaced by 4-methylpyrazole.
1 H NMR(400MHz,DMSO-d 6 ):δ11.00-11.06(d,1H),8.08(s,1H),7.82-7.85(d,1H),7.29-7.44(m,7H),7.05-7.08(t,1H),6.94-6.97(t,1H),6.41-6.42(d,1H),5.15-5.29(m,3H),3.23-3.36(m,2H),2.06(s,3H),1.67-1.74(dd,3H)。
The nuclear magnetic hydrogen spectrum of the compound 3 is shown in fig. 2.
EXAMPLE 4 preparation of Compound 4
Figure BDA0003568142520000073
The preparation method of the compound 4 is the same as that of the compound 1, and pyrazole is replaced by 3-methylpyrazole.
1 H NMR(400MHz,DMSO-d 6 ):δ10.99-11.04(d,1H),8.22(s,1H),7.30-7.44(m,7H),7.05-7.08(t,1H),6.94-6.97(t,1H),6.39-6.48(d,2H),5.18-5.27(m,3H),3.27-3.35(m,2H),2.31-2.42(m,3H),1.65-1.74(dd,3H)。
EXAMPLE 5 preparation of Compound 5
Figure BDA0003568142520000081
The preparation method of the compound 5 is the same as that of the compound 1, and pyrazole is replaced by 3-phenylpyrazole.
1 H NMR(400MHz,DMSO-d 6 ):δ10.97-11.05(d,1H),8.40(s,1H),7.99-8.06(m,2H),7.18-7.54(m,11H),7.06-7.09(t,1H),6.94-6.97(t,1H),6.51-6.58(dd,1H),5.19-5.30(m,3H),3.35-3.42(m,2H),1.61-1.62(d,3H)。
EXAMPLE 6 preparation of Compound 6
Figure BDA0003568142520000082
The preparation method of the compound 6 is the same as that of the compound 1, and pyrazole is replaced by 3-trifluoromethyl pyrazole.
1 H NMR(400MHz,DMSO-d 6 ):δ10.98-11.02(d,1H),8.59-8.61(d,1H),7.30-7.43(m,7H),7.13-7.14(d,1H),7.06-7.09(t,1H),6.95-6.98(t,1H),6.40(s,1H),5.12-5.28(m,3H),3.28-3.29(d,2H),1.47-1.58(dd,3H)。
EXAMPLE 7 preparation of Compound 7
Figure BDA0003568142520000083
The preparation method of the compound 7 is the same as that of the compound 1, and pyrazole is replaced by 3-ethoxycarbonyl pyrazole.
1 H NMR(400MHz,DMSO-d 6 ):δ10.99-11.01(d,1H),8.45-8.48(d,1H),7.29-7.43(m,7H),7.01-7.08(m,2H),6.95-6.96(d,1H),6.43(s,1H),5.21-5.25(d,3H),4.37-4.38(d,2H),3.23-3.38(m,2H),1.50-1.68(dd,3H),1.31-1.36(m,3H)。
The nuclear magnetic resonance hydrogen spectrum of the compound 7 is shown in fig. 3.
EXAMPLE 8 preparation of Compound 8
Figure BDA0003568142520000091
The preparation method of the compound 8 is the same as that of the compound 1, and pyrazole is replaced by 4-ethoxycarbonyl pyrazole.
1 H NMR(400MHz,DMSO-d 6 ):δ10.98-11.01(d,1H),8.75-8.81(d,1H),8.27-8.32(d,1H),7.30-7.43(m,7H),7.05-7.08(t,1H),6.94-6.97(t,1H),6.40(s,1H),5.15-5.28(m,3H),4.25-4.29(q,2H),3.24-3.36(m,2H),1.57-1.65(dd,3H),1.27-1.30(t,3H)。
The compounds shown in table 2 were prepared according to the scheme above:
TABLE 2
Figure BDA0003568142520000092
Figure BDA0003568142520000101
Figure BDA0003568142520000111
Example 9 determination of bactericidal Activity
The bactericidal activity of the tetrahydro-beta carboline pyrazole amide derivative compound prepared by the invention on plant pathogenic fungi is measured
1. Test plant pathogenic fungi
Rhizoctonia solani, rhizoctonia cerealis, and Sclerotinia sclerotiorum.
2. Indoor experiment method
The relative inhibition rate of hypha is measured by a toxic culture medium method:
Figure BDA0003568142520000121
firstly, diluting a tetrahydro-beta carboline pyrazole amide derivative compound with sterile water, then uniformly mixing the diluted compound with a PDA culture medium, and preparing a series of drug-containing plates with uniform thickness by adopting a double dilution method at the final concentration of the tetrahydro-beta carboline pyrazole amide derivative compound, wherein sterile water is used as a blank control, and each treatment is repeated for 3 times. After the culture medium is solidified, inoculating a test fungus cake of plant pathogenic fungi on the solidified culture medium, culturing for 3-5 days at 27-28 ℃, measuring the colony diameter by a crisscross method, and calculating the hypha growth inhibition rate, wherein the fungus cake diameter is 0.4 cm.
3. Experimental results
The determination results of the inhibitory activity of the tetrahydro-beta carboline pyrazole amide derivative compounds on plant pathogenic fungi are shown in table 3.
Table 3 relative inhibition of the phytopathogenic fungi of Compounds 1 to 16 at 20mg/L (%)
Figure BDA0003568142520000122
As shown in Table 3, the tetrahydro-beta carboline pyrazole amide derivative compound prepared by the invention has good inhibitory activity on plant pathogenic fungi at 20mg/L, is expected to be developed into a novel efficient green chemical pesticide, and has wide market application prospect.
4. Field efficacy experiment method
4.1 field efficacy test of different Compounds for controlling Botrytis cinerea of cucumber
4.11 test sites, methods of treatment and dosage
Test site: cao Wanglu Liu Cun in Boxing county; when the liquid medicine is prepared, a small amount of water is used for dissolving the medicament with the required amount for each treatment, and then water is added to the required water amount for each treatment concentration for uniform spraying. Compounds 1 to 16 were used for controlling cucumber gray mold by adding 10g of water 15L each.
4.12 investigation method
Five samples were taken per cell, 2 plants were investigated per spot, all leaves and all fruits of each plant were investigated, the disease-fruit rate was calculated and recorded separately according to the following classification method.
Leaf damage classification method (taking leaf as unit):
level 0: no disease spots;
stage 1:3 disease spots are arranged on a single leaf;
3 stages: single leaf with disease spots
Figure BDA0003568142520000132
5 stages: single leaf with disease spots
Figure BDA0003568142520000133
7 stages: the single leaf has 11-20 disease spots, and part of the single leaf is densely packed into a sheet;
stage 9: the single leaf has more than one quarter of densely-occupied disease spots.
4.13 investigation time and times
The disease cardinal number survey was performed prior to administration, two times, and the last survey was performed 10 days after the last administration.
4.14 method for calculating efficacy
The drug effect is calculated according to the formulas (1) and (2);
Figure BDA0003568142520000131
control effect (%) = (1- (ck0×pt1)/(ck1×pt0))×100 … … … (2)
Wherein: CK 0-index of disease prior to dosing in the placebo area;
CK 1-disease index after dosing in the placebo area;
PT 0-index of pre-dose condition in the dose treatment zone;
PT 1-disease index after administration in the agent treatment zone.
Table 4 control effect of Compounds 1 to 16 on cucumber gray mold at 10g/15L (%)
Figure BDA0003568142520000141
As shown in Table 4, the tetrahydro-beta carboline pyrazole amide derivative compound prepared by the invention has a strong control effect on cucumber gray mold at the dosage of 10 g/15L.
4.2 field efficacy test of different Compounds for controlling tomato downy mildew
4.21 test sites, methods of treatment and dosage
Test site: store town size Wang Cun; when the liquid medicine is prepared, a small amount of water is used for dissolving the medicament with the required amount for each treatment, and then water is added to the required water amount for each treatment concentration for uniform spraying. Compounds 1 to 16 were each used for controlling tomato downy mildew with 15g of water 15L.
4.22 investigation method
Four-point investigation is randomly carried out in each cell, two plants are investigated in each spot, and all the leaves are investigated in each plant.
Classification method (in leaf):
level 0: no disease spots;
stage 1: the area of the disease spots accounts for less than 5% of the whole leaf area;
3 stages: the area of the lesion occupying the whole leaf area
Figure BDA0003568142520000153
5 stages: the area of the lesion occupying the whole leaf area
Figure BDA0003568142520000154
7 stages: the area of the lesion occupying the whole leaf area
Figure BDA0003568142520000155
Stage 9: the area of the disease spots accounts for more than 50% of the whole leaf area.
4.23 investigation time and times
Disease number investigation was performed prior to administration, two times, and the last investigation was performed 10 days after the last administration.
4.24 method for calculating efficacy
The drug effect is calculated according to the formulas (1) and (2);
Figure BDA0003568142520000151
control effect (%) = (1- (ck0×pt1)/(ck1×pt0))×100 … … … (2)
Wherein: CK 0-index of disease prior to dosing in the placebo area;
CK 1-disease index after dosing in the placebo area;
PT 0-index of pre-dose condition in the dose treatment zone;
PT 1-disease index after administration in the agent treatment zone.
Table 5 control effect of Compounds 1 to 16 on tomato downy mildew at 15g/15L (%)
Figure BDA0003568142520000152
Figure BDA0003568142520000161
From Table 5, it is clear that the tetrahydro-beta carboline pyrazole amide derivative compound prepared by the invention has stronger control effect on tomato downy mildew at the dosage of 15 g/15L.
In conclusion, the tetrahydro-beta carboline pyrazole amide derivative compound prepared by the invention has good inhibitory activity on plant pathogenic fungi, is hopeful to be developed into a novel efficient green chemical pesticide, and has wide market application prospect.
The above description of the embodiments is only for aiding in the understanding of the method of the present invention and its core ideas. It should be noted that it will be apparent to those skilled in the art that various modifications and adaptations of the invention can be made without departing from the principles of the invention and these modifications and adaptations are intended to be within the scope of the invention as defined in the following claims.

Claims (7)

1. A tetrahydro-beta carboline pyrazole amide derivative having the structure shown in formula i:
Figure FDA0004194052340000011
wherein R is 1 Independently selected from one or more of H, halogen, C1-C6 alkyl, C1-C6 alkoxycarbonyl, difluoromethyl, trifluoromethyl, phenyl and halogen-containing substituted phenyl;
the R is 1 Is substituted in the 3-or 4-position;
R 2 is benzyloxy, methoxy;
R 3 selected from H;
R 4 selected from H;
R 5 selected from H;
x is O;
n is 1;
m is 1;
q is 1.
2. The tetrahydro- β carboline pyrazole amide derivative according to claim 1, having any one of the following structures:
Figure FDA0004194052340000012
Figure FDA0004194052340000021
3. the process for the preparation of a tetrahydro- β carboline pyrazole amide derivative according to any one of claims 1 to 2, comprising the steps of:
and mixing the tetrahydro-beta carboline amide and the pyrazole derivatives in a solvent, and reacting under the action of an acid binding agent and thionyl chloride to obtain the tetrahydro-beta carboline pyrazole amide derivatives.
4. The method according to claim 3, wherein the solvent is one or more selected from toluene, xylene, methylene chloride, dichloroethane, methyl tertiary butyl ether, tetrahydrofuran, dioxane, ethylene glycol dimethyl ether, acetone, ethyl acetate, acetonitrile;
the acid binding agent is an alkaline compound;
the alkaline compound is selected from one or more of potassium carbonate, sodium carbonate, potassium bicarbonate, sodium bicarbonate, triethylamine and pyridine;
the temperature of the reaction is 5-70 ℃.
5. A method of preparation according to claim 3, comprising the steps of:
s1) mixing tetrahydro-beta carboline amide and pyrazole derivatives in a solvent, and reacting under the action of an acid binding agent and thionyl chloride;
s2) after the reaction is finished, regulating the pH value of the system to 1-2, and separating to obtain an organic phase;
and S3) drying and purifying the organic phase to obtain the tetrahydro-beta carboline pyrazole amide derivative.
6. Use of a tetrahydro-beta carboline pyrazole amide derivative according to any one of claims 1 to 2 or a tetrahydro-beta carboline pyrazole amide derivative prepared by a preparation method according to any one of claims 3 to 5 as an active ingredient of an antibacterial agent.
7. An antibacterial agent comprising the tetrahydro- β carboline pyrazole amide derivative according to any one of claims 1 to 2 or the tetrahydro- β carboline pyrazole amide derivative prepared by the preparation method according to any one of claims 3 to 5.
CN202210310789.5A 2022-03-28 2022-03-28 Tetrahydro-beta-carboline pyrazole amide derivative and preparation method and application thereof Active CN114478525B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210310789.5A CN114478525B (en) 2022-03-28 2022-03-28 Tetrahydro-beta-carboline pyrazole amide derivative and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210310789.5A CN114478525B (en) 2022-03-28 2022-03-28 Tetrahydro-beta-carboline pyrazole amide derivative and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN114478525A CN114478525A (en) 2022-05-13
CN114478525B true CN114478525B (en) 2023-05-30

Family

ID=81487845

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210310789.5A Active CN114478525B (en) 2022-03-28 2022-03-28 Tetrahydro-beta-carboline pyrazole amide derivative and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114478525B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2707442A1 (en) * 2007-11-30 2009-08-20 Biota Scientific Management Pty Ltd Antibiotic tetrahydro-beta-carboline derivatives
EP3718405A1 (en) * 2009-05-27 2020-10-07 PTC Therapeutics, Inc. Methods for treating cancer and non-neoplastic conditions
CN104744460B (en) * 2013-12-30 2017-06-16 南开大学 β carbolines, dihydro β carbolines and tetrahydro-beta-carboline alcaloid-derivatives and preparation method thereof and the application in terms of preventing and treating plant virus, sterilization, desinsection

Also Published As

Publication number Publication date
CN114478525A (en) 2022-05-13

Similar Documents

Publication Publication Date Title
Siddiqui et al. Synthesis, characterization and antimicrobial evaluation of novel halopyrazole derivatives
Dai et al. The thiazoylmethoxy modification on pyrazole oximes: Synthesis and insecticidal biological evaluation beyond acaricidal activity
Fang et al. Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents
EP3459951B1 (en) Tetrahydro-beta-carboline alkaloid derivatives, method for preparing the same and use in aspects of preventing and treating plant viruses, as fungicides and insecticides
Kühler et al. Novel Structures Derived from 2-[[(2-Pyridyl) methyl] thio]-1 H-benzimidazole as Anti-Helicobacter p ylori Agents, Part 1
Yang et al. Synthesis of novel (E)-2-(4-(1 H-1, 2, 4-triazol-1-yl) styryl)-4-(alkyl/arylmethyleneoxy) quinazoline derivatives as antimicrobial agents
EP3725776B1 (en) Pyrazole amide compound and application thereof, and fungicide
Aouad Click Synthesis and antimicrobial screening of novel isatin-1, 2, 3-triazoles with piperidine, morpholine, or piperazine moieties
Raimondi et al. Synthesis and anti-staphylococcal activity of new 4-diazopyrazole derivatives
Yao et al. Design, synthesis and biological evaluation of thiazole and imidazo [1, 2-a] pyridine derivatives containing a hydrazone substructure as potential agrochemicals
Malhotra et al. Synthesis, characterization and pharmacological evaluation of (Z)-2-(5-(biphenyl-4-yl)-3-(1-(imino) ethyl)-2, 3-dihydro-1, 3, 4-oxadiazol-2-yl) phenol derivatives as potent antimicrobial and antioxidant agents
CN106397422A (en) Nicotinamide compound containing chiral oxazoline and application of same as agricultural bactericide
Chavan et al. Synthesis, characterization, and biological activities of some 3, 5, 6-trichloropyridine derivatives
CN114478525B (en) Tetrahydro-beta-carboline pyrazole amide derivative and preparation method and application thereof
Kumar et al. Synthesis and antimicrobial activity of novel 1, 4, 5-triphenyl-1 H-imidazol-[1, 2, 3]-triazole derivatives
Li et al. Discovery of a new fungicide by screening triazole sulfonylhydrazone derivatives and its downy mildew inhibition in cucumber
Singh et al. Synthesis and antimicrobial activity of some 2-phenyl-benzoxazole derivatives
CN111393359A (en) Pyridine salt-containing N- (cinnamoyl) -N' - (substituted) propyl hydrazide compound and preparation method and application thereof
Liu et al. Design, synthesis, and antifungal activities of novel sulfoximine derivatives for plant protection
JP5866710B2 (en) Plant drying tolerance imparting method and plant drying tolerance imparting agent used therefor
Bhavanarushi et al. F (1H‐Pyrazol‐4‐yl) methylene‐Hydrazide derivatives: Synthesis and antimicrobial activity
CN104628646B (en) N Pyrazolylcarboxanilides classes compound, intermediate, composition, preparation method and application
GB2088872A (en) 1-benzylimidazole derivatives
CN115108978B (en) Pyridine formylhydrazine plant antifungal medicine
Arshad et al. (E)-Substituted-N-((1, 3-diphenyl-1H-pyrazol-4-yl) methylene) benzeneamine: synthesis, characterization, antibacterial, and MTT assessment

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 256599 Economic Development Zone, Boxing County, Binzhou City, Shandong Province

Applicant after: Shandong Jingbo Agrochemical Technology Co.,Ltd.

Address before: 256599 Economic Development Zone, Boxing County, Binzhou City, Shandong Province

Applicant before: JINGBO AGROCHEMICALS TECHNOLOGY Co.,Ltd.

CB02 Change of applicant information
GR01 Patent grant
GR01 Patent grant